Secukinumab

Secukinumab is a human interleukin-17A antagonist indicated for the treatment of:

  • Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy
  • Adults with active psoriatic arthritis (PsA)
  • Adults with active ankylosing spondylitis (AS)

There are no products to list in this category.

Continue